Can I Take Vitamin B12 with Lisinopril? A Women's Health Guide

The short answer: vitamin B12 and lisinopril do not interact directly

Lisinopril and vitamin B12 work through completely separate biological pathways, so they do not interfere with each other's absorption, metabolism, or effect. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that lowers blood pressure by blocking the conversion of angiotensin I to angiotensin II. Vitamin B12 (cobalamin) is a water-soluble micronutrient involved in DNA synthesis, red blood cell formation, and myelin production. There is no pharmacokinetic collision between the two.

You do not need to separate the timing of these two by hours. You do not need to choose one over the other. What you do need to understand is why your broader medication list, particularly any metformin you may also be taking, changes the picture entirely.

Why clinicians still bring up B12 in lisinopril conversations

Women are often prescribed lisinopril for hypertension, heart failure, diabetic nephropathy, or CKD. A significant share of those same women are also on metformin, either for type 2 diabetes or for PCOS. Metformin interferes with ileal calcium-dependent absorption of the B12-intrinsic factor complex, leading to measurable B12 reduction in roughly 10 to 30 percent of long-term users. The lisinopril is not the culprit. The combination of clinical context matters, and it is common enough that any prescriber managing a woman on both drugs should be asking about B12 status.

What "no direct interaction" actually means

No interaction means:

• Lisinopril does not reduce B12 absorption in the gut
• B12 does not alter lisinopril's blood-pressure-lowering effect
• B12 does not change lisinopril's half-life, protein binding, or renal clearance
• Lisinopril does not accelerate B12 urinary excretion

This is confirmed across major drug-interaction databases including Drugs.com interaction checker and the Natural Medicines database, neither of which lists a clinically significant interaction between ACE inhibitors and cyanocobalamin or methylcobalamin.

Why B12 status matters for women on lisinopril specifically

Women who are prescribed lisinopril are not a homogeneous group. Your hormonal status, your age, your co-prescriptions, and your dietary pattern each create a different B12 risk profile. This section walks through the groups where B12 deserves more than a passing thought.

Women with PCOS on metformin plus lisinopril

PCOS affects an estimated 8 to 13 percent of women of reproductive age globally. Many of those women are prescribed metformin to address insulin resistance, and a subset later develop hypertension that warrants an ACE inhibitor like lisinopril, particularly if they also have CKD-range proteinuria from diabetes-related kidney disease.

A 2006 study in the British Medical Journal found that metformin use was independently associated with vitamin B12 deficiency, and that the deficiency worsened with longer duration of use and higher doses. Women with PCOS who have been on metformin for more than two years and who now add lisinopril to their regimen are not adding a B12 risk via the lisinopril itself. But the clinical visit that leads to the lisinopril prescription is a good opportunity to check whether the existing metformin has already depleted B12 stores.

Symptoms of B12 deficiency that overlap with PCOS symptoms include fatigue, brain fog, and mood changes, making clinical recognition harder without lab confirmation.

Perimenopausal and postmenopausal women

Perimenopause and postmenopause introduce two independent B12 risk factors.

First, estrogen decline is associated with increased rates of atrophic gastritis, a condition in which gastric acid and intrinsic factor production decrease. Atrophic gastritis is present in up to 30 percent of adults over 60 and directly impairs B12 absorption from food. Crystalline B12 in supplements is absorbed passively and bypasses this pathway, which is why supplementation becomes more effective than dietary B12 alone in this life stage.

Second, postmenopausal women with hypertension are one of the most common groups prescribed lisinopril. If they are also taking a proton pump inhibitor (PPI) for reflux, another medication that reduces gastric acid, B12 absorption is further compromised. Long-term PPI use is associated with a 65 percent increased risk of B12 deficiency according to a large Kaiser Permanente study published in JAMA in 2013.

Women with type 2 diabetes and CKD

Lisinopril is a first-line agent for diabetic nephropathy. Women with type 2 diabetes and CKD face overlapping risks: metformin-related B12 depletion, reduced dietary protein (which often tracks with reduced animal-product intake in CKD dietary management), and sometimes the presence of diabetic gastroparesis, which slows gastric emptying and can further impair nutrient absorption.

CKD also affects the interpretation of serum B12 labs. Methylmalonic acid (MMA) and homocysteine are more reliable functional markers of B12 adequacy in women with impaired kidney function, since CKD independently elevates homocysteine through non-B12 mechanisms.

How vitamin B12 deficiency actually damages the nervous system

This is not a theoretical concern. Peripheral neuropathy from B12 deficiency presents as numbness, tingling, or burning in the feet and hands. Subacute combined degeneration of the spinal cord is the severe end of that spectrum, involving demyelination of the dorsal and lateral columns. Women may notice symptoms that look like diabetic neuropathy, which is why B12-related neuropathy often goes unrecognized in women who already have diabetes.

Megaloblastic anemia is the hematologic manifestation: large, immature red blood cells that carry oxygen poorly. Fatigue, pallor, and shortness of breath follow.

The serum B12 level considered deficient varies by laboratory but is commonly defined as below 200 pg/mL, with a gray zone from 200 to 300 pg/mL where functional deficiency may exist without frank deficiency by standard cutoffs. In that gray zone, measuring MMA is the next step.

Sex-specific physiology: does being a woman change any of this?

Yes, in several ways that most general articles do not address.

Menstrual cycle and B12 absorption

Estrogen and progesterone fluctuations across the menstrual cycle affect gastrointestinal motility and gastric acid secretion, though the effect on B12 absorption specifically has not been studied in adequately powered prospective trials. This is one of the documented evidence gaps in women's nutrition research. Extrapolating from gastrointestinal physiology, luteal-phase progesterone-driven slowing of gut transit may theoretically reduce B12 absorption from food, but direct evidence in reproductive-age women is absent.

A practical framework for women in reproductive years: treat your B12 need as year-round rather than cycle-dependent. Consistent daily supplementation is more reliable than sporadic dosing because B12 stores replete gradually, with hepatic stores typically covering three to five years of zero dietary intake in a previously replete adult.

Pregnancy and women trying to conceive

Lisinopril is contraindicated in pregnancy. This is not a soft advisory. ACE inhibitors including lisinopril cause fetal renal tubular dysplasia, oligohydramnios, skull hypoplasia, and neonatal death. The FDA classifies lisinopril as Pregnancy Category D in the first trimester and Category X from the second trimester onward. Any woman on lisinopril who is trying to conceive must discuss contraception and blood-pressure management alternatives with her prescriber before attempting pregnancy.

ACOG recommends labetalol, nifedipine extended-release, or methyldopa as first-line antihypertensive options in pregnancy. Lisinopril must be stopped before pregnancy, not after a positive test.

B12, by contrast, is not only safe in pregnancy but is essential. Adequate B12 supports neural tube closure alongside folate. The recommended dietary allowance for B12 in pregnancy is 2.6 mcg per day, and most prenatal vitamins include it. Deficiency during pregnancy is associated with increased risk of neural tube defects and adverse neurodevelopmental outcomes in the infant.

Lactation

Lisinopril passes into breast milk in small amounts, and its safety in lactating women has not been established. Most guidelines recommend avoiding ACE inhibitors during breastfeeding or switching to an agent with a better-characterized lactation safety profile. Discuss alternatives with your prescriber if you are breastfeeding.

B12 transfers into breast milk and is the primary source of B12 for exclusively breastfed infants. Infants born to B12-deficient mothers or breastfed by B12-deficient mothers are at high risk of B12 deficiency themselves, which can cause irreversible neurological damage in infants. If you are lactating and on metformin, B12 supplementation and monitoring are especially important.

Pregnancy, lactation, and contraception: the required safety section

Lisinopril in pregnancy: contraindicated. Do not take it.

If you are on lisinopril and not using reliable contraception, speak to your prescriber today. This is not a category where waiting to see a positive pregnancy test is safe. ACE inhibitor exposure even in the first trimester has been associated with congenital cardiovascular malformations in some observational studies, though this remains an area of ongoing debate. The fetal renal toxicity from second and third trimester exposure is not debated.

Recommended contraception while on lisinopril: any reliable method including combined oral contraceptives (noting that estrogen-containing OCs can themselves raise blood pressure in some women, which requires monitoring), progestin-only pills, IUDs, implants, or barrier methods.

B12 in pregnancy and lactation: safe and encouraged.

No upper tolerable intake level has been established for B12 because excess is excreted in urine. Supplementing at standard prenatal doses (2.6 mcg/day in pregnancy, 2.8 mcg/day while breastfeeding) or at the higher doses often used to replete deficiency (1,000 mcg/day oral for metformin-related depletion) carries no known fetal or infant risk.

Who this is right for, and who should be more cautious

Women who can take B12 and lisinopril together without concern

• You are not on metformin
• You are not on a PPI long-term
• You are under 50 with no gastric conditions
• Your serum B12 is in the normal range on recent labs
• You eat a varied diet that includes animal products regularly

For this group, a standard B12 supplement (typically 25 to 100 mcg/day in a multivitamin, or up to 1,000 mcg as a standalone if preferred) alongside lisinopril requires no special precaution and no timing separation.

Women who need B12 monitoring before assuming all is well

• You take metformin at any dose, for PCOS or diabetes
• You are over 50, perimenopausal, or postmenopausal
• You take a PPI (omeprazole, pantoprazole, esomeprazole)
• You follow a vegetarian or vegan diet
• You have CKD, type 2 diabetes with neuropathy, or unexplained fatigue and tingling
• You are pregnant or breastfeeding and your prenatal does not specify B12 content

For this group, the question is not whether B12 is safe with lisinopril. The question is whether you are already B12-deficient and whether your prescriber knows to check.

Women who should stop lisinopril entirely and discuss alternatives

• You are pregnant or planning to become pregnant in the next three to six months
• You are breastfeeding and your prescriber has not confirmed safety
• You are in the first trimester and your lisinopril was not yet switched

What form and dose of B12 should you take?

Vitamin B12 comes in several forms: cyanocobalamin (the most studied and cost-effective), methylcobalamin (the active coenzyme form, preferred by some clinicians for neurological indications), hydroxocobalamin (used in injectable formulations), and adenosylcobalamin.

Oral cyanocobalamin at 1,000 mcg/day has been shown to be as effective as intramuscular injection for correcting B12 deficiency in most people without malabsorption from pernicious anemia, because approximately 1 percent of very high oral doses is absorbed passively, bypassing intrinsic factor. For metformin-related depletion, oral repletion at 1,000 mcg/day is the most practical approach.

For women without deficiency who simply want maintenance coverage alongside their lisinopril, the amount in a standard multivitamin (6 to 25 mcg) is sufficient. Higher doses are not harmful but are not necessary for prevention alone.

No dose of B12 needs to be timed away from lisinopril. Take both whenever it fits your routine.

Monitoring: what your labs should include

If you take metformin with lisinopril, ask your prescriber at your next visit for:

1. Serum B12 (annual, at minimum)
2. Methylmalonic acid (MMA) if serum B12 falls between 200 and 300 pg/mL
3. Complete blood count (CBC) to detect macrocytosis before anemia develops
4. Homocysteine as a secondary functional marker, with the caveat that CKD independently raises it

The American Diabetes Association Standards of Care recommend periodic measurement of B12 in patients on long-term metformin, particularly those with peripheral neuropathy or anemia.

This recommendation applies to your prescriber's checklist regardless of whether you are also on lisinopril. The lisinopril does not add to B12 monitoring burden. It does, however, often signal a clinical picture where other monitoring gaps may exist.

The evidence gap: what we do not know yet

Women have been underrepresented in cardiovascular and nephrology trials. Most pharmacokinetic data on lisinopril comes from trials where women represented fewer than 30 to 40 percent of participants, and subgroup analyses by sex were rarely powered adequately. The CONSENSUS and SOLVD trials that established ACE inhibitor benefit in heart failure enrolled predominantly male populations.

For B12-lisinopril specifically, there are no prospective trials examining B12 status in women on ACE inhibitors compared to those not on ACE inhibitors. The current conclusion that lisinopril does not deplete B12 is based on the known mechanism (no shared metabolic pathway, no known effect on gastric intrinsic factor, no ileal calcium-dependent transport involvement), not on a large prospective women's cohort study. That distinction matters. The mechanistic argument is strong. The direct clinical evidence in women is absent.

If you develop neurological symptoms (tingling, numbness, balance problems, cognitive changes) while on lisinopril, do not assume the drug is to blame or not to blame. Get your B12 checked. Female-specific neuropathy workup should include B12 status as standard.

Practical checklist before you take B12 with lisinopril

• [ ] Confirm your current medication list includes lisinopril and identify any other medications that affect B12 (metformin, PPIs, H2 blockers)
• [ ] Ask your prescriber when your last serum B12 was checked
• [ ] If you have been on metformin for more than one year, request B12 now if it has not been checked in the past 12 months
• [ ] Choose a B12 form: cyanocobalamin for general repletion, methylcobalamin if your prescriber prefers the active form for neurological indications
• [ ] If you are of reproductive age and on lisinopril, confirm you are using reliable contraception
• [ ] If you are planning pregnancy, do not wait. Contact your prescriber to transition off lisinopril before attempting to conceive